Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0; the clinical trial record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T16:21:27.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.5%
    Check dated 2026-10-25T16:34:29.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new version of the study record was added, submitted on 2026-10-15 and posted on 2026-10-16, with a change to the study status.
    Difference
    0.4%
    Check dated 2026-10-18T22:16:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:12:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed, indicating an update to the history log's versioning metadata. This change does not alter study data or core content.
    Difference
    0.1%
    Check dated 2026-09-20T19:44:55.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The record history shows an update to recruitment status, indicating the trial is active but not currently enrolling participants. This signals that enrollment is not open at this time.
    Difference
    0.1%
    Check dated 2026-09-06T22:49:12.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.